Commitments and Contingencies - Part-4 (Details) |
1 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Nov. 22, 2019
USD ($)
|
Nov. 22, 2019
GBP (£)
|
Aug. 20, 2018
shares
|
Dec. 31, 2024
shares
|
Dec. 31, 2023
shares
|
|
Commitments and Contingencies [Line Items] | |||||
Percentage of net product sales of royalties | 1.00% | ||||
Common stock, shares, issued (in Shares) | 3,176,999 | 534,719 | |||
Kennedy License Agreement [Member] | |||||
Commitments and Contingencies [Line Items] | |||||
Royalties description | 180 LP will also pay Kennedy royalties equal to (i) 1% of the net sales for the first annual GBP £1 million (USD $1,283,400) of net sales, and (ii) 2% of the net sales after the net sales are at or in excess of GBP £1 million, as well as 25% of all sublicense revenue, provided that the amount of such percentage of sublicense revenue based on amounts which constitute royalties shall not be less than 1% on the first cumulative GBP £1 million of net sales of the products sold by such sublicenses or their affiliates, and 2% on that portion of the cumulative net sales of the products sold by such sublicenses or their affiliates in excess of GBP £1 million. | ||||
Petcanna Sub-License Agreement [Member] | |||||
Commitments and Contingencies [Line Items] | |||||
Common shares of its share capital (in Shares) | 450,000 | ||||
Oxford University Agreements [Member] | |||||
Commitments and Contingencies [Line Items] | |||||
Percentage of shares issued | 85.00% | ||||
Hebrew University of Jerusalem Ltd [Member] | |||||
Commitments and Contingencies [Line Items] | |||||
Percentage of shares issued | 15.00% | ||||
Petcanna Subsidiary [Member] | |||||
Commitments and Contingencies [Line Items] | |||||
Common stock, shares, issued (in Shares) | 450,000 | ||||
LP [Member] | Kennedy License Agreement [Member] | |||||
Commitments and Contingencies [Line Items] | |||||
Upfront fee paid for intangible assets | $ 74,000 | £ 60,000 |
X | ||||||||||
- Definition A description of the royalties of net sales. No definition available.
|
X | ||||||||||
- Definition Percentage of net product sales of royalties. No definition available.
|
X | ||||||||||
- Definition Percentage of shares issued. No definition available.
|
X | ||||||||||
- Definition The amount of upfront fee paid for intangible assets. No definition available.
|
X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|